Cargando…

Designing a next generation multi-epitope based peptide vaccine candidate against SARS-CoV-2 using computational approaches

COVID-19 caused by SARS-CoV-2 was declared a global pandemic by WHO (World Health Organization) in March, 2020. Within 6 months, nearly 750,000 deaths are claimed by COVID-19 across the globe. This called for immediate social, scientific, technological, public and community interventions. Considerin...

Descripción completa

Detalles Bibliográficos
Autores principales: Saha, Ratnadeep, Ghosh, Pratik, Burra, V. L. S. Prasad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7799423/
https://www.ncbi.nlm.nih.gov/pubmed/33457172
http://dx.doi.org/10.1007/s13205-020-02574-x
_version_ 1783635127945920512
author Saha, Ratnadeep
Ghosh, Pratik
Burra, V. L. S. Prasad
author_facet Saha, Ratnadeep
Ghosh, Pratik
Burra, V. L. S. Prasad
author_sort Saha, Ratnadeep
collection PubMed
description COVID-19 caused by SARS-CoV-2 was declared a global pandemic by WHO (World Health Organization) in March, 2020. Within 6 months, nearly 750,000 deaths are claimed by COVID-19 across the globe. This called for immediate social, scientific, technological, public and community interventions. Considering the severity of infection and the associated mortalities, global efforts are underway to develop preventive measures against SARS-CoV-2. Among the SARS-CoV-2 target proteins, Spike (S) glycoprotein (a.k.a S Protein) is the most studied target known to trigger strong host immune response. A detailed analysis of S protein-based epitopes enabled us to design a novel B-cell-derived T-cell Multi-epitope-based peptide (MEBP) vaccine candidate. This involved a systematic and comprehensive computational protocol consisting of prediction of dual-purpose epitopes and designing an MEBP vaccine construct. This was followed by 3D structure validation, MEBP complex interaction studies, in silico cloning and vaccine dose-based immune response simulation to evaluate the immunogenic potency of the vaccine construct. The dual-purpose epitope prediction protocol was designed such that the same epitope elicits both humoral and cellular immune response unlike the earlier designs. Further, the epitopes predicted were screened against stringent criteria to ensure selection of a potent candidate with maximum antigen coverage and best immune response. The vaccine dose-based immune response simulation studies revealed a rapid antigen clearance through antibody generation and elevated levels of cell-mediated immunity during repeated exposure of the vaccine. The favourable results of the analysis strongly indicate that the vaccine construct is indeed a potent vaccine candidate and ready to proceed to the next steps of experimental validation and efficacy studies. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s13205-020-02574-x.
format Online
Article
Text
id pubmed-7799423
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-77994232021-01-12 Designing a next generation multi-epitope based peptide vaccine candidate against SARS-CoV-2 using computational approaches Saha, Ratnadeep Ghosh, Pratik Burra, V. L. S. Prasad 3 Biotech Original Article COVID-19 caused by SARS-CoV-2 was declared a global pandemic by WHO (World Health Organization) in March, 2020. Within 6 months, nearly 750,000 deaths are claimed by COVID-19 across the globe. This called for immediate social, scientific, technological, public and community interventions. Considering the severity of infection and the associated mortalities, global efforts are underway to develop preventive measures against SARS-CoV-2. Among the SARS-CoV-2 target proteins, Spike (S) glycoprotein (a.k.a S Protein) is the most studied target known to trigger strong host immune response. A detailed analysis of S protein-based epitopes enabled us to design a novel B-cell-derived T-cell Multi-epitope-based peptide (MEBP) vaccine candidate. This involved a systematic and comprehensive computational protocol consisting of prediction of dual-purpose epitopes and designing an MEBP vaccine construct. This was followed by 3D structure validation, MEBP complex interaction studies, in silico cloning and vaccine dose-based immune response simulation to evaluate the immunogenic potency of the vaccine construct. The dual-purpose epitope prediction protocol was designed such that the same epitope elicits both humoral and cellular immune response unlike the earlier designs. Further, the epitopes predicted were screened against stringent criteria to ensure selection of a potent candidate with maximum antigen coverage and best immune response. The vaccine dose-based immune response simulation studies revealed a rapid antigen clearance through antibody generation and elevated levels of cell-mediated immunity during repeated exposure of the vaccine. The favourable results of the analysis strongly indicate that the vaccine construct is indeed a potent vaccine candidate and ready to proceed to the next steps of experimental validation and efficacy studies. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s13205-020-02574-x. Springer International Publishing 2021-01-11 2021-02 /pmc/articles/PMC7799423/ /pubmed/33457172 http://dx.doi.org/10.1007/s13205-020-02574-x Text en © King Abdulaziz City for Science and Technology 2021
spellingShingle Original Article
Saha, Ratnadeep
Ghosh, Pratik
Burra, V. L. S. Prasad
Designing a next generation multi-epitope based peptide vaccine candidate against SARS-CoV-2 using computational approaches
title Designing a next generation multi-epitope based peptide vaccine candidate against SARS-CoV-2 using computational approaches
title_full Designing a next generation multi-epitope based peptide vaccine candidate against SARS-CoV-2 using computational approaches
title_fullStr Designing a next generation multi-epitope based peptide vaccine candidate against SARS-CoV-2 using computational approaches
title_full_unstemmed Designing a next generation multi-epitope based peptide vaccine candidate against SARS-CoV-2 using computational approaches
title_short Designing a next generation multi-epitope based peptide vaccine candidate against SARS-CoV-2 using computational approaches
title_sort designing a next generation multi-epitope based peptide vaccine candidate against sars-cov-2 using computational approaches
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7799423/
https://www.ncbi.nlm.nih.gov/pubmed/33457172
http://dx.doi.org/10.1007/s13205-020-02574-x
work_keys_str_mv AT saharatnadeep designinganextgenerationmultiepitopebasedpeptidevaccinecandidateagainstsarscov2usingcomputationalapproaches
AT ghoshpratik designinganextgenerationmultiepitopebasedpeptidevaccinecandidateagainstsarscov2usingcomputationalapproaches
AT burravlsprasad designinganextgenerationmultiepitopebasedpeptidevaccinecandidateagainstsarscov2usingcomputationalapproaches